CN101269156B - Chinese medicinal composition for treating eye disease - Google Patents
Chinese medicinal composition for treating eye disease Download PDFInfo
- Publication number
- CN101269156B CN101269156B CN2008100115122A CN200810011512A CN101269156B CN 101269156 B CN101269156 B CN 101269156B CN 2008100115122 A CN2008100115122 A CN 2008100115122A CN 200810011512 A CN200810011512 A CN 200810011512A CN 101269156 B CN101269156 B CN 101269156B
- Authority
- CN
- China
- Prior art keywords
- fructus
- restrains
- semen
- grams
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention relates to a traditional Chinese medicine composition for curing nearsightedness, which comprises the following raw medicines of viter rotundifolia, pilose antler, glossy privet fruit, medlar, feather cockscomb seed, earthworm and gentianella. The traditional Chinese medicine can clear away heat and toxic material, relieve the depressed liver, activate blood and improve eyesight andcan be used for curing nearsightedness, amblyopia and pseudomyopia.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of ophthalmic, specifically relate to a kind of Chinese medicine composition for the treatment of disease of eye such as myopia, amblyopia, pseudomyopia.
Background technology
Myopia and amblyopia and pseudomyopia are one of common ophthalmic diseases, and clinical symptoms shows as patient for fuzzy than far object identification, need wear glasses for the myopia and can see object clearly.Doctor trained in Western medicine thinks that the endogenous cause of ill of ophthalmic diseases mainly contains heredity and these two aspects of developmental factors, wherein, throwback's near-sighted sickness rate early, and how more than 6 diopters (600 degree), this high myopia is due to the autosomal recessive inheritance, but, the participation of environmental factors is also arranged; Developmental factors is meant that axis oculi is long, then forms myopia, and exopathogenic factor is eye strain and environmental pollution, and malnutrition etc. causes.Based on this viewpoint, doctor trained in Western medicine is a surgical operation at treatment ophthalmic diseases method majority, but this method causes postoperative infection and recurrence easily and stay in various degree sequela to the patient, can not tackle the problem at its root.
And theory of Chinese medical science is thought, liver is had one's ideas straightened out and makes eye bright, and myopia and ophthalmics such as amblyopia and pseudomyopia are that body immunity is low when being deficient syndrome because of liver, when excess eye-using is tired, also occur ophthalmics such as myopia easily.So, the bathomorphic method of traditional Chinese medical science traditional treatment then only is to be confined to eye health protection massage or single folk prescription treatment among the people, as: Herba Dendrobii oral liquid or the like, these methods can alleviated bathomorphic further developing in various degree, but still can not fundamentally effect a radical cure this type of disease.
" preparation of compound mixture and the method for inspection thereof " of Chinese patent 1895552A Granted publication provides an example that utilizes the treatment by Chinese herbs ophthalmic.This patent adopt 15 flavor Chinese medicines such as Semen Cassiae, Rhizoma Coptidis behind compatibility Chinese medicine composition as the medicine of treatment ophthalmic.According to existing theory of Chinese medical science, the treatment ophthalmic adopts the medicine of the liver benefiting mostly, Semen Cassiae, Radix Ophiopogonis etc., but, the negative and positive imbalance also is the main cause that disease produces, and the heart is a deficient syndrome simultaneously, is the son of liver because of the heart, illness of the child-organ affecting the motherone also can cause deficiency of the liver, and ophthalmic also easily takes place; On the other hand, it is prosperous excessively that the spleen lung is crossed Sheng, and when being the case of a physically strong patient running a high fever, because of lung is a gold, spleen be native, when the lung gold prosperous excessively, metal restricting wood, liver damage; Spleen soil is prosperous excessively, the anti-gram of spleen soil edema with the liver involved, and liver is also impaired, thus utilize the treatment by Chinese herbs ophthalmic will be from the heart, spleen, lung, and many-side such as equilibrium between yin and yang considers, and different medicines, curative effect is not quite similar.
Summary of the invention
Purpose of the present invention just provides the Chinese medicine composition of a kind of more efficiently treatment myopia, amblyopia, pseudomyopia.
The present invention has selected the crude drug of following weight quota: Fructus Viticis 20-50 part, Cornu Cervi Pantotrichum 10-40 part, Fructus Ligustri Lucidi and each 10-30 part of Fructus Lycii, Semen Celosiae, Pheretima and each 2-15 part of Radix Gentianae are made up, make each efficacy of drugs produce synergism these drug regimens, thereby can effectively treat diseases such as myopia, amblyopia, pseudomyopia.Wherein select for use Fructus Viticis to be because this medicine is returned Liver Channel, have the effect of clearing away heat to improve acuity of vision, motherland's traditional medicine is thought: liver opening at eye, so, the scheme of the most of Chinese traditional treatments of ophthalmic diseases all is devoted to hepatoprotective, nourishing the liver, and Fructus Viticis is commanded whole prescription as this pharmaceutical composition monarch drug; Cornu Cervi Pantotrichum, Fructus Ligustri Lucidi and Fructus Lycii are as ministerial drug, mainly carry out proportioning according to the theory of traditional Chinese medical science mutual generation of five phases restriction or checking relation in five elements, traditional medicine is thought: liver belongs to wood the five elements, kidney belongs to water the five elements, theory according to " water generating wood " in the five-elements theory, carry out in various degree tonification for human kidney, can promote the quick improvement of hepatic disease, Cornu Cervi Pantotrichum wherein is the crude drug of effect the best in the medicine of kidney invigorating and YANG supporting just, and Fructus Ligustri Lucidi and Fructus Lycii both the kidney invigorating can tonifying liver, Semen Celosiae has suppressing the hyperactive liver to dredge the effect that Yu Xiere makes eye bright, Radix Gentianae has the knot effect, and knot goes under the courage, and then order can be bright, select Pheretima mainly according to traditional Chinese medical science equilibrium between yin and yang theory in the crude drug, use its dredging the meridian.
Also comprise Semen Cassiae 20-60 part, Semen Cuscutae 10-40 part, Rhizoma Cimicifugae 2-15 part in the crude drug.Semen Cassiae is similar to the property of medicine of Fructus Viticis, can be used as the monarch drug of this pharmaceutical composition, plays the effect of the whole prescription of commander, and Semen Cuscutae is as ministerial drug, and Semen Cuscutae is the preferable medicine of effect in the kidney invigorating medicine, and Rhizoma Cimicifugae is returned the spleen lung meridian, the effect that has heat-clearing and toxic substances removing to make eye bright.
Also comprise Flos Buddlejae 20-50 part, Magnetitum 5-30 part, Herba Dendrobii and each 10-30 part of Rhizoma Acori Graminei in the crude drug.Flos Buddlejae is similar to the property of medicine of Semen Cassiae and Fructus Viticis, and Herba Dendrobii also is the preferable medicine of effect in the kidney invigorating medicine, and the Rhizoma Acori Graminei the kidney invigorating again can tonifying liver, and Magnetitum has the effect of auxiliary monarch drug as ministerial drug.
Also comprise Semen Pruni 5-20 part, Faeces Vespertilionis 5-20 part, Fructus Tribuli 5-30 part, Semen Plantaginis 5-30 part, Fructus Leonuri 5-20 part, Herba Senecionis Scandentis 5-30 part in the crude drug.Semen Pruni has the knot effect, and knot goes under the courage, and Semen Plantaginis and Herba Senecionis Scandentis are the ministerial drugs of auxiliary monarch drug, and Fructus Tribuli has suppressing the hyperactive liver to dredge the effect that Yu Xiere makes eye bright, and Fructus Leonuri makes eye bright beneficial smart, the effect of the nourishing the liver benefit heart.
Also comprise Rhizoma Coptidis 5-25 part, Radix Glycyrrhizae 5-25 part, Rhizoma Chuanxiong and each 5-20 part of Radix Rehmanniae in the crude drug.Rhizoma Coptidis and Radix Glycyrrhizae can play heat-clearing and toxic substances removing, the effect that makes eye bright and dispel the wind, and Radix Rehmanniae is led heart channel deficiency-heat, the tonifying kidneys, strengthening heart that can make eye bright, Rhizoma Chuanxiong is returned the liver and gall warp, and the effect of blood-activating and qi-promoting Yin Yang balancing is arranged.
The consumption of medicine components of the present invention is also groped to sum up to draw through the inventor in a large number, and the each component consumption proportion has better curative effect in the following weight parts ratio range.
The weight quota of described crude drug is: Fructus Viticis 20-50 part, Cornu Cervi Pantotrichum 10-40 part, Fructus Ligustri Lucidi and each 10-30 part of Fructus Lycii, Semen Celosiae, Pheretima and each 2-15 part of Radix Gentianae, Semen Cassiae 20-60 part, Semen Cuscutae 10-40 part, Rhizoma Cimicifugae 2-15 part.
The weight quota of described crude drug is: Fructus Viticis 20-50 part, Cornu Cervi Pantotrichum 10-40 part, Fructus Ligustri Lucidi and each 10-30 part of Fructus Lycii, Semen Celosiae 2-15 part, Pheretima and each 2-15 part of Radix Gentianae, Flos Buddlejae 20-50 part, Magnetitum 5-30 part, Herba Dendrobii and each 10-30 part of Rhizoma Acori Graminei.
The weight quota of described crude drug is: Fructus Viticis 20-50 part, Cornu Cervi Pantotrichum 10-40 part, Fructus Ligustri Lucidi and each 10-30 part of Fructus Lycii, Semen Celosiae, Pheretima and each 2-15 part of Radix Gentianae, Semen Cassiae 20-60 part, Semen Cuscutae 10-40 part, Rhizoma Cimicifugae 2-15 part, Flos Buddlejae 20-50 part, Magnetitum 5-30 part, Herba Dendrobii and each 10-30 part of Rhizoma Acori Graminei.
The weight quota of described crude drug is: Fructus Viticis 20-50 part, Cornu Cervi Pantotrichum 10-40 part, each 10-30 part of Fructus Ligustri Lucidi and Fructus Lycii, Semen Celosiae, each 2-15 part of Pheretima and Radix Gentianae, Semen Cassiae 20-60 part, Semen Cuscutae 10-40 part, Rhizoma Cimicifugae 2-15 part, Flos Buddlejae 20-50 part, Magnetitum 5-30 part, each 10-30 part of Herba Dendrobii and Rhizoma Acori Graminei, Semen Pruni 5-20 part, Faeces Vespertilionis 5-20 part, Fructus Tribuli 5-30 part, Semen Plantaginis 5-30 part, Fructus Leonuri 5-20 part, Herba Senecionis Scandentis 5-30 part, Rhizoma Coptidis 5-25 part, Radix Glycyrrhizae 5-25 part, each 5-20 part of Rhizoma Chuanxiong and Radix Rehmanniae.
Medicine of the present invention can adopt the conventional method of Chinese medicine preparation to be prepared into any conventional oral preparations.As: pill, powder, tablet etc., it is best especially each crude drug pulverize mix homogeneously to be made capsule effect for oral administration.
The present invention has heat-clearing and toxic substances removing, depressed liver-energy dispersing and QI regulating, and the effect of blood circulation-activating eyesight-improving is used for the treatment of myopia, amblyopia, pseudomyopia.
Below further set forth the beneficial effect of medicine of the present invention by testing example.
The test example:
1, physical data
Each 10 example of selection of clinical myopia masculinity and femininity patient, wherein 10 years old-15 years old 4 examples, 15 years old-23 years old 6 examples, 23 years old-28 years old 4 examples, 28 years old-35 years old 3 examples, 35 years old-45 years old 3 examples.
2, diagnostic criteria
In the case, 1 people's vision about 0.7, wherein 9 for each person vision 0.5,8 for each person vision 0.9,2 for each person vision 0.7.
3, Therapeutic Method
Adopt the capsule preparations made, every contains crude drug 5 grams, and every day is early, middle and late respectively takes one to the patient, and 15 days is a course of treatment, minimum taking continuously 3 courses of treatment.
4, efficacy assessment standard
Produce effects: vision improves fast, observes 3 months no bounce-back persons.
Take a turn for the better: vision has raising slightly, and can maintain on the existing vision level and do not worsen.
5, therapeutic outcome
Continuous 15 days, vision improved 0.2-0.3 person's 3 examples on original basis; Took continuously 30 days, vision improves 0.3-0.5 person's 10 examples on original basis; Continued to take medicine 30 days, vision is increased to 1.0-1.2 and not bounce-back person 5 examples; Take medicine to maintain in 30 days enhancer's 2 examples are arranged on the original vision basis slightly.Comparing result: produce effects 18 examples, 2 examples that take a turn for the better, obvious effective rate is 90%, and improvement rate is 10%, and total effective rate is 90%.
The specific embodiment:
Embodiment 1
Weighting raw materials Fructus Viticis 357 grams, Cornu Cervi Pantotrichum 179 grams, Fructus Ligustri Lucidi 179 grams, Fructus Lycii 179 grams, Semen Celosiae 36 grams, Pheretima 36, Radix Gentianae 36 restrain respectively.Then with each crude drug pulverize state, and mix homogeneously, after 45 ℃ of-50 ℃ of following dryings, just made the active constituent of medicine of the present invention.Every accurately takes by weighing active constituent 5 and restrains the snap fit capsule of packing into.
Embodiment 2
Weighting raw materials Fructus Viticis 257 grams, Cornu Cervi Pantotrichum 205 grams, Fructus Ligustri Lucidi 154 grams, Fructus Lycii 154 grams, Semen Celosiae 77 grams, Pheretima 77, Radix Gentianae 77 restrain respectively.Make the active constituent of medicine of the present invention then according to embodiment 1, and take by weighing the active constituent 5 gram snap fit capsule of packing into.
Embodiment 3
Weighting raw materials Fructus Viticis 282 grams, Cornu Cervi Pantotrichum 202 grams, Fructus Ligustri Lucidi 160 grams, Fructus Lycii 160 grams, Semen Celosiae 50 grams, Pheretima 45, Radix Gentianae 50 restrain respectively.Make the active constituent of medicine of the present invention then according to embodiment 1, and take by weighing the active constituent 5 gram snap fit capsule of packing into.
Embodiment 4
Respectively weighting raw materials Fructus Viticis 227 grams, Cornu Cervi Pantotrichum 114 grams, Fructus Ligustri Lucidi 114 grams, each 114 gram of Fructus Lycii, Semen Celosiae 23 grams, Pheretima 23 grams, each 23 gram of Radix Gentianae, Semen Cassiae 227 grams, Semen Cuscutae 114 grams, Rhizoma Cimicifugae 23 grams.Make the active constituent of medicine of the present invention then according to embodiment 1, and take by weighing the active constituent 5 gram snap fit capsule of packing into.
Embodiment 5
Fructus Viticis 161 grams, Cornu Cervi Pantotrichum 129 grams, Fructus Ligustri Lucidi 97 grams, Fructus Lycii 97 grams, Semen Celosiae 48 grams, Pheretima 48 grams, Radix Gentianae 48 grams, Semen Cassiae 194 grams, Semen Cuscutae 129 grams, Rhizoma Cimicifugae 48 grams.Make the active constituent of medicine of the present invention then according to embodiment 1, and take by weighing the active constituent 5 gram snap fit capsule of packing into.
Embodiment 6
Difference weighting raw materials Fructus Viticis 181 restrains, Cornu Cervi Pantotrichum 130 restrains, Fructus Ligustri Lucidi 104 restrains, Fructus Lycii 104 restrains, Semen Celosiae 36 restrains, Pheretima 36 restrains, Radix Gentianae 36 restrains, Semen Cassiae 207 restrains, Semen Cuscutae 129 restrains, Rhizoma Cimicifugae 36 restrains.Make the active constituent of medicine of the present invention then according to embodiment 1, and take by weighing the active constituent 5 gram snap fit capsule of packing into.
Embodiment 7
Difference weighting raw materials Fructus Viticis 219 restrains, Cornu Cervi Pantotrichum 109 restrains, Fructus Ligustri Lucidi 109 restrains, Fructus Lycii 109 restrains, Semen Celosiae 22 restrains, Pheretima 22 restrains, Radix Gentianae 22 restrains, Flos Buddlejae 219 restrains, Magnetitum 55 restrains, Herba Dendrobii 109 restrains, Rhizoma Acori Graminei 109 restrains.Make the active constituent of medicine of the present invention then according to embodiment 1, and take by weighing the active constituent 5 gram snap fit capsule of packing into.
Embodiment 8
Difference weighting raw materials Fructus Viticis 164 restrains, Cornu Cervi Pantotrichum 131 restrains, Fructus Ligustri Lucidi 98 restrains, Fructus Lycii 98 restrains, Semen Celosiae 49 restrains, Pheretima 49 restrains, Radix Gentianae 49 restrains, Flos Buddlejae 164 restrains, Magnetitum 98 restrains, Herba Dendrobii 98 restrains, Rhizoma Acori Graminei 98 restrains.Make the active constituent of medicine of the present invention then according to embodiment 1, and take by weighing the active constituent 5 gram snap fit capsule of packing into.
Embodiment 9
Difference weighting raw materials Fructus Viticis 166 restrains, Cornu Cervi Pantotrichum 118 restrains, Fructus Ligustri Lucidi 95 restrains, Fructus Lycii 95 restrains, Semen Celosiae 33 restrains, Pheretima 33 restrains, Radix Gentianae 33 restrains, Flos Buddlejae 142 restrains, Magnetitum 95 restrains, Herba Dendrobii 95 restrains, Rhizoma Acori Graminei 95 restrains.Make the active constituent of medicine of the present invention then according to embodiment 1, and take by weighing the active constituent 5 gram snap fit capsule of packing into.
Embodiment 10
Difference weighting raw materials Fructus Viticis 150 restrains, Cornu Cervi Pantotrichum 75 restrains, Fructus Ligustri Lucidi 75 restrains, Fructus Lycii 75 restrains, Semen Celosiae 15 restrains, Pheretima 15 restrains, Radix Gentianae 15 restrains, Semen Cassiae 150 restrains, Semen Cuscutae 75 restrains, Rhizoma Cimicifugae 15 restrains, Flos Buddlejae 150 restrains, Magnetitum 37 restrains, Herba Dendrobii 75 restrains, Rhizoma Acori Graminei 75 restrains.Make the active constituent of medicine of the present invention then according to embodiment 1, and take by weighing the active constituent 5 gram snap fit capsule of packing into.
Embodiment 11
Fructus Viticis 128 grams, Cornu Cervi Pantotrichum 90 grams, Fructus Ligustri Lucidi 73 grams, Fructus Lycii 73 grams, Semen Celosiae 25 grams, Pheretima 25 grams, Radix Gentianae 25 grams, Semen Cassiae 146 grams, Semen Cuscutae 90 grams, Rhizoma Cimicifugae 25 grams, Flos Buddlejae 109 grams, Magnetitum 73 grams, Herba Dendrobii 55 grams, Rhizoma Acori Graminei 55 grams.Make the active constituent of medicine of the present invention then according to embodiment 1, and take by weighing the active constituent 5 gram snap fit capsule of packing into.
Embodiment 12
Respectively weighting raw materials Fructus Viticis 113 grams, Cornu Cervi Pantotrichum 56 grams, Fructus Ligustri Lucidi 56 grams, Fructus Lycii 56 grams, Semen Celosiae 12 grams, Pheretima 12 grams, each 12 gram of Radix Gentianae, Semen Cassiae 113 grams, Semen Cuscutae 113 grams, Rhizoma Cimicifugae 12 grams, Flos Buddlejae 113 grams, Magnetitum 28 grams, Herba Dendrobii 56 grams, Rhizoma Acori Graminei 56 grams, Semen Pruni 28 grams, Faeces Vespertilionis 28 grams, Fructus Tribuli 28 grams, Semen Plantaginis 28 grams, Fructus Leonuri 28 grams, Herba Senecionis Scandentis 28 grams, Rhizoma Coptidis 28 grams, Radix Glycyrrhizae 28 grams, Rhizoma Chuanxiong 28 grams, Radix Rehmanniae 28 gram.Make the active constituent of medicine of the present invention then according to embodiment 1, and take by weighing the active constituent 5 gram snap fit capsule of packing into.
Embodiment 13
Difference weighting raw materials Fructus Viticis 72 restrains, Cornu Cervi Pantotrichum 57 restrains, Fructus Ligustri Lucidi 43 restrains, Fructus Lycii 43 restrains, Semen Celosiae 21 restrains, Pheretima 21 restrains, Radix Gentianae 21 restrains, Semen Cassiae 86 restrains, Semen Cuscutae 57 restrains, Rhizoma Cimicifugae 21 restrains, Flos Buddlejae 72 restrains, Magnetitum 43 restrains, Herba Dendrobii 43 restrains, Rhizoma Acori Graminei 43 restrains, Semen Pruni 29 restrains, Faeces Vespertilionis 29 restrains, Fructus Tribuli 43 restrains, Semen Plantaginis 43 restrains, Fructus Leonuri 28 restrains, Herba Senecionis Scandentis 43 restrains, Rhizoma Coptidis 36 restrains, Radix Glycyrrhizae 36 restrains, Rhizoma Chuanxiong 28 restrains, Radix Rehmanniae 28 restrains.Make the active constituent of medicine of the present invention then according to embodiment 1, and take by weighing the active constituent 5 gram snap fit capsule of packing into.
Embodiment 14
Difference weighting raw materials Fructus Viticis 84 restrains, Cornu Cervi Pantotrichum 60 restrains, Fructus Ligustri Lucidi 48 restrains, Fructus Lycii 48 restrains, Semen Celosiae 16 restrains, Pheretima 16 restrains, Radix Gentianae 16 restrains, Semen Cassiae 95 restrains, Semen Cuscutae 60 restrains, Rhizoma Cimicifugae 16 restrains, Flos Buddlejae 84 restrains, Magnetitum 48 restrains, Herba Dendrobii 35 restrains, Rhizoma Acori Graminei 36 restrains, Semen Pruni 31 restrains, Faeces Vespertilionis 36 restrains, Fructus Tribuli 28 restrains, Semen Plantaginis 28 restrains, Fructus Leonuri 33 restrains, Herba Senecionis Scandentis 36 restrains, Rhizoma Coptidis 38 restrains, Radix Glycyrrhizae 38 restrains, Rhizoma Chuanxiong 33 restrains, Radix Rehmanniae 33 restrains.Make the active constituent of medicine of the present invention then according to embodiment 1, and take by weighing the active constituent 5 gram snap fit capsule of packing into.
Claims (4)
1. the Chinese medicine composition of treatment ophthalmic is characterized in that this Chinese medicine composition contains the crude drug of following weight quota: Fructus Viticis 20-50 part, Cornu Cervi Pantotrichum 10-40 part, Fructus Ligustri Lucidi and each 10-30 part of Fructus Lycii, Semen Celosiae, Pheretima and each 2-15 part of Radix Gentianae.
2. Chinese medicine composition according to claim 1 is characterized in that: the weight quota of described crude drug is: Fructus Viticis 20-50 part, Cornu Cervi Pantotrichum 10-40 part, Fructus Ligustri Lucidi and each 10-30 part of Fructus Lycii, Semen Celosiae, Pheretima and each 2-15 part of Radix Gentianae, Semen Cassiae 20-60 part, Semen Cuscutae 10-40 part, Rhizoma Cimicifugae 2-15 part.
3. Chinese medicine composition according to claim 1 is characterized in that the weight quota of described crude drug is: Fructus Viticis 20-50 part, Cornu Cervi Pantotrichum 10-40 part, Fructus Ligustri Lucidi and each 10-30 part of Fructus Lycii, Semen Celosiae 2-15 part, Pheretima and each 2-15 part of Radix Gentianae, Flos Buddlejae 20-50 part, Magnetitum 5-30 part, Herba Dendrobii and each 10-30 part of Rhizoma Acori Graminei.
3, Chinese medicine composition according to claim 1 is characterized in that the weight quota of crude drug is: Fructus Viticis 20-50 part, Cornu Cervi Pantotrichum 10-40 part, Fructus Ligustri Lucidi and each 10-30 part of Fructus Lycii, Semen Celosiae, Pheretima and each 2-15 part of Radix Gentianae, Semen Cassiae 20-60 part, Semen Cuscutae 10-40 part, Rhizoma Cimicifugae 2-15 part, Flos Buddlejae 20-50 part, Magnetitum 5-30 part, Herba Dendrobii and each 10-30 part of Rhizoma Acori Graminei.
4. Chinese medicine composition according to claim 1 is characterized in that the weight quota of described crude drug is: Fructus Viticis 20-50 part, Cornu Cervi Pantotrichum 10-40 part, each 10-30 part of Fructus Ligustri Lucidi and Fructus Lycii, Semen Celosiae, each 2-15 part of Pheretima and Radix Gentianae, Semen Cassiae 20-60 part, Semen Cuscutae 10-40 part, Rhizoma Cimicifugae 2-15 part, Flos Buddlejae 20-50 part, Magnetitum 5-30 part, each 10-30 part of Herba Dendrobii and Rhizoma Acori Graminei, Semen Pruni 5-20 part, Faeces Vespertilionis 5-20 part, Fructus Tribuli 5-30 part, Semen Plantaginis 5-30 part, Fructus Leonuri 5-20 part, Herba Senecionis Scandentis 5-30 part, Rhizoma Coptidis 5-25 part, Radix Glycyrrhizae 5-25 part, each 5-20 part of Rhizoma Chuanxiong and Radix Rehmanniae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100115122A CN101269156B (en) | 2008-05-22 | 2008-05-22 | Chinese medicinal composition for treating eye disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100115122A CN101269156B (en) | 2008-05-22 | 2008-05-22 | Chinese medicinal composition for treating eye disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101269156A CN101269156A (en) | 2008-09-24 |
| CN101269156B true CN101269156B (en) | 2011-02-16 |
Family
ID=40003547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100115122A Expired - Fee Related CN101269156B (en) | 2008-05-22 | 2008-05-22 | Chinese medicinal composition for treating eye disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101269156B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101579488B (en) * | 2009-06-16 | 2011-01-26 | 唐凯 | Chinese medicament for treating cataract and glaucoma |
| CN102754756B (en) * | 2012-08-08 | 2013-12-18 | 上海比瑞吉宠物用品有限公司 | Natural plant feed additive for improving tear stains of poodles and preparation method thereof |
| CN103520517B (en) * | 2013-10-18 | 2015-08-05 | 卞佳林 | Presbyopic pharmaceutical composition of a kind of control and preparation method thereof |
| CN107412571A (en) * | 2017-09-06 | 2017-12-01 | 王文春 | A kind of medicine for treating photophobia and preparation method thereof |
| CN109602844A (en) * | 2019-01-22 | 2019-04-12 | 贵州侗家寨医药科技有限公司 | A kind of Chinese medicine spongarion and preparation method thereof for treating myopia and amblyopia |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1079885A (en) * | 1993-03-12 | 1993-12-29 | 侯小滨 | Pillow for treatment of myopia |
| CN1149481A (en) * | 1996-04-16 | 1997-05-14 | 郭良才 | Capsule for enhancing eyesight |
| CN1411823A (en) * | 2001-10-11 | 2003-04-23 | 籍文艳 | Medicine for curing myopia and amblyopia and its preparation method |
-
2008
- 2008-05-22 CN CN2008100115122A patent/CN101269156B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1079885A (en) * | 1993-03-12 | 1993-12-29 | 侯小滨 | Pillow for treatment of myopia |
| CN1149481A (en) * | 1996-04-16 | 1997-05-14 | 郭良才 | Capsule for enhancing eyesight |
| CN1411823A (en) * | 2001-10-11 | 2003-04-23 | 籍文艳 | Medicine for curing myopia and amblyopia and its preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101269156A (en) | 2008-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102772770B (en) | Traditional Chinese medicine composition for treating cold-damp affecting spleen syndrome | |
| CN101632819B (en) | Preparation for resisting suppression of bone marrow after lung cancer chemotherapy | |
| CN101269156B (en) | Chinese medicinal composition for treating eye disease | |
| US9241966B1 (en) | External-use traditional chinese medicine for ichthyosis and xerodermia, and preparation method thereof | |
| CN102526345B (en) | Chinese medicinal composition for treating hypertension | |
| CN106236875A (en) | A kind of Chinese medicine composition of liver heat removing and eyesight improving and preparation method thereof | |
| CN101884715B (en) | Medicament for treating optic neuritis and preparation method thereof | |
| CN100391499C (en) | Chewing gum for radiation protection | |
| CN105362642A (en) | Traditional Chinese medicine for treating menstrual vertigo with syndrome of yin deficiency and yang hyperactivity | |
| CN104055841B (en) | A kind for the treatment of and pre-myopic-preventing pharmaceutical composition | |
| CN107929670A (en) | A kind of Medicated eye-mask for treating eye-blurred and preparation method thereof | |
| CN103830552A (en) | Traditional Chinese medicine composition for treating Meniere's disease | |
| CN103169882A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN101185704B (en) | Powder agent medicine for treating aphtha | |
| CN104800663A (en) | Traditional Chinese medicinal liquor for treating hyperostosis and preparation method of traditional Chinese medicinal liquor | |
| CN105148150A (en) | Healthcare tea and making method thereof | |
| CN104800491A (en) | Oral solution with superstrong function of improving human immunity | |
| CN110404056A (en) | A kind of pure Chinese medicine eye sticker and preparation method thereof | |
| CN1136870C (en) | Medicine for treating rheumatism | |
| CN104258295A (en) | Traditional Chinese medicine decoction for treating lymphoma | |
| CN104173737A (en) | Traditional Chinese medicine formula for treating pulmonary interstitial fibrosis | |
| CN115444903A (en) | Application of rehabilitation eyesight oral liquid in preparation of eyesight improving medicine | |
| CN1689599A (en) | Chinese medicinal preparation for treating cerebral apoplexy | |
| CN103816493B (en) | A kind of Chinese medicine composition treating instability of kidney QI | |
| CN108079073A (en) | It is a kind of steep pedicure tremble with fear foot alleviate medicine Chinese medicine powder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110216 Termination date: 20160522 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |